Carbone, F.; Meessen, J.; Magnoni, M.; Andreini, D.; Maggioni, A.P.; Latini, R.; Montecucco, F., on behalf of the CAPIRE Investigators.
Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE Study. Cells 2022, 11, 669.
https://doi.org/10.3390/cells11040669
AMA Style
Carbone F, Meessen J, Magnoni M, Andreini D, Maggioni AP, Latini R, Montecucco F on behalf of the CAPIRE Investigators.
Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE Study. Cells. 2022; 11(4):669.
https://doi.org/10.3390/cells11040669
Chicago/Turabian Style
Carbone, Federico, Jennifer Meessen, Marco Magnoni, Daniele Andreini, Aldo Pietro Maggioni, Roberto Latini, and Fabrizio Montecucco on behalf of the CAPIRE Investigators.
2022. "Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE Study" Cells 11, no. 4: 669.
https://doi.org/10.3390/cells11040669
APA Style
Carbone, F., Meessen, J., Magnoni, M., Andreini, D., Maggioni, A. P., Latini, R., & Montecucco, F., on behalf of the CAPIRE Investigators.
(2022). Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE Study. Cells, 11(4), 669.
https://doi.org/10.3390/cells11040669